bioAffinity Technologies (BIAF) Accounts Payables (2022 - 2025)
Historic Accounts Payables for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $940761.0.
- bioAffinity Technologies' Accounts Payables rose 2015.79% to $940761.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $940761.0, marking a year-over-year increase of 2015.79%. This contributed to the annual value of $987311.0 for FY2024, which is 6324.88% up from last year.
- Per bioAffinity Technologies' latest filing, its Accounts Payables stood at $940761.0 for Q3 2025, which was up 2015.79% from $1.2 million recorded in Q2 2025.
- bioAffinity Technologies' Accounts Payables' 5-year high stood at $1.4 million during Q1 2025, with a 5-year trough of $146537.0 in Q1 2023.
- In the last 4 years, bioAffinity Technologies' Accounts Payables had a median value of $782937.0 in 2024 and averaged $672505.0.
- Its Accounts Payables has fluctuated over the past 5 years, first skyrocketed by 45209.42% in 2023, then crashed by 537.46% in 2024.
- bioAffinity Technologies' Accounts Payables (Quarter) stood at $345042.0 in 2022, then skyrocketed by 75.28% to $604789.0 in 2023, then surged by 63.25% to $987311.0 in 2024, then fell by 4.71% to $940761.0 in 2025.
- Its last three reported values are $940761.0 in Q3 2025, $1.2 million for Q2 2025, and $1.4 million during Q1 2025.